Literature DB >> 19090798

Trends in imported malaria to Basel, Switzerland.

Clara Thierfelder1, Catherine Schill, Christoph Hatz, Reto Nüesch.   

Abstract

BACKGROUND: Due to persistent international travel and immigration trends, imported malaria remains to be of clinical and public health importance in nonendemic countries. The aim of this study was to investigate trends in imported malaria over a period of more than three decades.
METHODS: We assessed travel history, demographic characteristics, and clinical course with special regard to malaria diagnosis and intensive care unit (ICU) admission of patients diagnosed with malaria. The sample comprised 109 patients with the diagnosis of malaria according to the International Statistical Classification of Diseases and Related Health Problems (ICD)-coding system (versions 9 and 10) at the University Hospital and at a teaching hospital in Basel between January 1994 and June 2004. Changes in clinical management and outcomes were compared with previous studies at the same institutions dating back to the 1970s.
RESULTS: The most common reason for travel was to visit friends and relatives in the country of origin (37%), and most infections were acquired in Africa (82%), with Plasmodium falciparum malaria the most frequently found parasite (84%). The mean time between first symptoms and the diagnosis of malaria was 4 days (range 0.5-31 d). Delay in diagnosis occurred in 14% of cases, and 37% of hospitalized patients were referred to the ICU. In 22% of referred cases, high parasitemia (>2%) according to internal criteria was a reason for referral. The course of disease remained mild in the great majority (90%) of patients, and none of the patients died.
CONCLUSIONS: Prompt and specific diagnosis of malaria could be improved. Malaria-associated mortality was reduced over time. As ICU referral showed to be inappropriately high in relation to a moderate clinical course of several admitted patients, criteria for ICU admission should be reevaluated. The trend toward malaria in patients originating from endemic areas suggests that preventive travel advice should specifically address these patients.

Entities:  

Mesh:

Year:  2008        PMID: 19090798     DOI: 10.1111/j.1708-8305.2008.00251.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

Review 1.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Imported falciparum malaria among adults requiring intensive care: analysis of the literature.

Authors:  Michael Marks; Margaret Armstrong; David Walker; Tom Doherty
Journal:  Malar J       Date:  2014-03-05       Impact factor: 2.979

3.  Malaria and other febrile diseases among travellers: the experience of a reference centre located outside the Brazilian Amazon Region.

Authors:  Andréa Beltrami Doltario; Lucas José Bazzo Menon; Valdes Roberto Bollela; Roberto Martinez; Daniel Cardoso de Almeida E Araújo; Benedito Antônio Lopes da Fonseca; Rodrigo de C Santana
Journal:  Malar J       Date:  2016-05-26       Impact factor: 2.979

4.  Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London.

Authors:  Michael E Marks; Margaret Armstrong; Muhiddin M Suvari; Steve Batson; Christopher J M Whitty; Peter L Chiodini; Geoff Bellinghan; Justin F Doherty
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

Review 5.  Managing malaria in the intensive care unit.

Authors:  M Marks; A Gupta-Wright; J F Doherty; M Singer; D Walker
Journal:  Br J Anaesth       Date:  2014-06-19       Impact factor: 9.166

6.  Acute kidney injury in imported Plasmodium falciparum malaria.

Authors:  Liese C Koopmans; Marlies E van Wolfswinkel; Dennis A Hesselink; Ewout J Hoorn; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2015-12-24       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.